Mcl-1 was upregulated after bortezomib exposure in all neuroblastoma cell lines whereas no change was identified in Bcl2, XIAP, survivin and Bcl-xl expression after bortezomib treatment (figure 5). This evidence concerns the gene MCL1 and neuroblastoma.